All lobbying filings

VENABLE LLP

Lobbying for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA · Non-profit product development partnership

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 1

SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Budget/Appropriations

FY 2027 Labor, Health and Human Services, Education and State and Foreign Operations funding for global health research and development and neglected tropical diseases; FY 2027 global health research and development funding; Issues related to global health.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.